{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:26:35Z","timestamp":1761222395121,"version":"build-2065373602"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011612","name":"University Grants Commission - Sri Lanka","doi-asserted-by":"publisher","award":["UGC\/VC\/DRIC\/PG2019(I)\/RUH\/01"],"award-info":[{"award-number":["UGC\/VC\/DRIC\/PG2019(I)\/RUH\/01"]}],"id":[{"id":"10.13039\/501100011612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21010-9","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:53:40Z","timestamp":1761220420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum erythropoietin and its determinants and associations in patients with haemoglobin E \u03b2-thalassaemia"],"prefix":"10.1038","volume":"15","author":[{"given":"Dinusha","family":"Amarasingha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiromi","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuja","family":"Premawardhena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachith","family":"Mettananda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"21010_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","volume":"391","author":"AT Taher","year":"2018","unstructured":"Taher, A. T., Weatherall, D. J. & Cappellini, M. D. Thalassaemia. Lancet 391, 155\u2013167. https:\/\/doi.org\/10.1016\/S0140-6736(17)31822-6 (2018).","journal-title":"Lancet"},{"key":"21010_CR2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(05)67396-5","volume":"366","author":"A Premawardhena","year":"2005","unstructured":"Premawardhena, A. et al. Haemoglobin E beta thalassaemia in Sri Lanka. Lancet 366, 1467\u20131470. https:\/\/doi.org\/10.1016\/S0140-6736(05)67396-5 (2005).","journal-title":"Lancet"},{"key":"21010_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.hoc.2017.11.003","volume":"32","author":"S Mettananda","year":"2018","unstructured":"Mettananda, S. & Higgs, D. R. Molecular basis and genetic modifiers of thalassemia. Hematol. Oncol. Clin. North Am. 32, 177\u2013191. https:\/\/doi.org\/10.1016\/j.hoc.2017.11.003 (2018).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"21010_CR4","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1016\/S2214-109X(21)00446-0","volume":"10","author":"AP Premawardhena","year":"2022","unstructured":"Premawardhena, A. P. et al. Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: A prospective, longitudinal cohort study. Lancet Glob. Health 10, e134\u2013e141. https:\/\/doi.org\/10.1016\/S2214-109X(21)00446-0 (2022).","journal-title":"Lancet Glob. Health"},{"key":"21010_CR5","doi-asserted-by":"publisher","first-page":"a011619","DOI":"10.1101\/cshperspect.a011619","volume":"3","author":"HF Bunn","year":"2013","unstructured":"Bunn, H. F. Erythropoietin. Cold Spring Harb. Perspect. Med. 3, a011619 (2013).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"21010_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/08880019709030902","volume":"14","author":"G Ni\u015fli","year":"1997","unstructured":"Ni\u015fli, G., Kavakli, K., Aydinok, Y., Oztop, S. & Ceting\u00fcl, N. Serum erythropoietin levels in patients with beta thalassemia major and intermedia. Pediatr. Hematol. Oncol. 14, 161\u2013167. https:\/\/doi.org\/10.3109\/08880019709030902 (1997).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"21010_CR7","doi-asserted-by":"publisher","first-page":"394295","DOI":"10.1155\/2013\/394295","volume":"2013","author":"JA Ribeil","year":"2013","unstructured":"Ribeil, J. A. et al. Ineffective erythropoiesis in \u03b2 -thalassemia. Sci. World J. 2013, 394295. https:\/\/doi.org\/10.1155\/2013\/394295 (2013).","journal-title":"Sci. World J."},{"key":"21010_CR8","doi-asserted-by":"publisher","first-page":"978710","DOI":"10.1155\/2010\/978710","volume":"2010","author":"J Amer","year":"2010","unstructured":"Amer, J., Dana, M. & Fibach, E. The antioxidant effect of erythropoietin on thalassemic blood cells. Anemia 2010, 978710 (2010).","journal-title":"Anemia"},{"key":"21010_CR9","doi-asserted-by":"publisher","first-page":"978710","DOI":"10.1155\/2010\/978710","volume":"2010","author":"J Amer","year":"2010","unstructured":"Amer, J., Dana, M. & Fibach, E. The antioxidant effect of erythropoietin on thalassemic blood cells. Anemia 2010, 978710. https:\/\/doi.org\/10.1155\/2010\/978710 (2010).","journal-title":"Anemia"},{"key":"21010_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1749-6632.1998.tb10470.x","volume":"850","author":"EA Rachmilewitz","year":"1998","unstructured":"Rachmilewitz, E. A. & Aker, M. The role of recombinant human erythropoietin in the treatment of thalassemia. Ann. N. Y. Acad. Sci. 850, 129\u2013138. https:\/\/doi.org\/10.1111\/j.1749-6632.1998.tb10470.x (1998).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"21010_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/ejh.12182","volume":"91","author":"MS Elalfy","year":"2013","unstructured":"Elalfy, M. S., Adly, A. A., Ismail, E. A., Elhenawy, Y. I. & Elghamry, I. R. Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in young \u03b2-thalassemia intermedia patients. Eur. J. Haematol. 91, 522\u2013533. https:\/\/doi.org\/10.1111\/ejh.12182 (2013).","journal-title":"Eur. J. Haematol."},{"key":"21010_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/tropej\/42.6.330","volume":"42","author":"G Ni\u015fli","year":"1996","unstructured":"Ni\u015fli, G., Kavakli, K., Vergin, C., \u00d6ztop, S. & \u00c7eting\u00fcl, N. Recombinant human erythropoietin trial in thalassemia intermedia. J. Trop. Pediatr. 42, 330\u2013334. https:\/\/doi.org\/10.1093\/tropej\/42.6.330 (1996).","journal-title":"J. Trop. Pediatr."},{"key":"21010_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bcmd.2014.11.007","volume":"54","author":"P Butthep","year":"2015","unstructured":"Butthep, P., Wisedpanichkij, R., Jindadamrongwech, S. & Fucharoen, S. Elevated erythropoietin and cytokines levels are related to impaired reticulocyte maturation in thalassemic patients. Blood Cells Mol. Dis. 54, 170\u2013176. https:\/\/doi.org\/10.1016\/j.bcmd.2014.11.007 (2015).","journal-title":"Blood Cells Mol. Dis."},{"key":"21010_CR14","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1073\/pnas.0703424104","volume":"104","author":"A O\u2019Donnell","year":"2007","unstructured":"O\u2019Donnell, A. et al. Age-related changes in adaptation to severe anemia in childhood in developing countries. Proc. Natl. Acad. Sci. USA 104, 9440\u20139444. https:\/\/doi.org\/10.1073\/pnas.0703424104 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"21010_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1182\/blood-2012-12-471441","volume":"122","author":"SR Pasricha","year":"2013","unstructured":"Pasricha, S. R., Frazer, D. M., Bowden, D. K. & Anderson, G. J. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with beta-thalassemia major: A longitudinal study. Blood 122, 124\u2013133. https:\/\/doi.org\/10.1182\/blood-2012-12-471441 (2013).","journal-title":"Blood"},{"key":"21010_CR16","doi-asserted-by":"publisher","first-page":"e0125215","DOI":"10.1371\/journal.pone.0125215","volume":"10","author":"N Grote Beverborg","year":"2015","unstructured":"Grote Beverborg, N. et al. Erythropoietin in the general population: Reference ranges and clinical, biochemical and genetic correlates. PLoS ONE 10, e0125215. https:\/\/doi.org\/10.1371\/journal.pone.0125215 (2015).","journal-title":"PLoS ONE"},{"key":"21010_CR17","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/j.1532-5415.2005.53416.x","volume":"53","author":"WB Ershler","year":"2005","unstructured":"Ershler, W. B. et al. Serum erythropoietin and aging: A longitudinal analysis. J. Am. Geriatr. Soc. 53, 1360\u20131365. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53416.x (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"21010_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bcmd.2008.04.005","volume":"41","author":"EA Price","year":"2008","unstructured":"Price, E. A. Aging and erythropoiesis: Current state of knowledge. Blood Cells Mol. Dis. 41, 158\u2013165. https:\/\/doi.org\/10.1016\/j.bcmd.2008.04.005 (2008).","journal-title":"Blood Cells Mol. Dis."},{"key":"21010_CR19","first-page":"311","volume":"9","author":"J Porter","year":"2015","unstructured":"Porter, J. & Garbowski, M. Novel erythropoiesis stimulating agents in thalassemia. Eur. Hematol. Assoc. Educ. Prog. 9, 311\u2013320 (2015).","journal-title":"Eur. Hematol. Assoc. Educ. Prog."},{"key":"21010_CR20","doi-asserted-by":"publisher","first-page":"1497588","DOI":"10.3389\/fphys.2025.1497588","volume":"16","author":"K Turpaev","year":"2025","unstructured":"Turpaev, K. et al. An overview of hereditary spherocytosis and the curative effects of splenectomy. Front. Physiol. 16, 1497588 (2025).","journal-title":"Front. Physiol."},{"key":"21010_CR21","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/S0140-6736(22)00536-0","volume":"399","author":"A Kattamis","year":"2022","unstructured":"Kattamis, A., Kwiatkowski, J. L. & Aydinok, Y. Thalassaemia. Lancet 399, 2310\u20132324. https:\/\/doi.org\/10.1016\/S0140-6736(22)00536-0 (2022).","journal-title":"Lancet"},{"key":"21010_CR22","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1111\/j.1538-7836.2010.03940.x","volume":"8","author":"A Taher","year":"2010","unstructured":"Taher, A. et al. Splenectomy and thrombosis: The case of thalassemia intermedia. J. Thromb. Haemost. 8, 2152\u20132158 (2010).","journal-title":"J. Thromb. Haemost."},{"key":"21010_CR23","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1136\/hrt.2005.079970","volume":"92","author":"A Phrommintikul","year":"2006","unstructured":"Phrommintikul, A., Sukonthasarn, A., Kanjanavanit, R. & Nawarawong, W. Splenectomy: A strong risk factor for pulmonary hypertension in patients with thalassaemia. Heart 92, 1467\u20131472 (2006).","journal-title":"Heart"},{"key":"21010_CR24","doi-asserted-by":"publisher","first-page":"e041958","DOI":"10.1136\/bmjopen-2020-041958","volume":"10","author":"N Yasara","year":"2020","unstructured":"Yasara, N. et al. Efficacy and safety of oral hydroxyurea in transfusion-dependent beta-thalassaemia: A protocol for randomised double-blind controlled clinical trial. BMJ Open 10, e041958. https:\/\/doi.org\/10.1136\/bmjopen-2020-041958 (2020).","journal-title":"BMJ Open"},{"key":"21010_CR25","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1038\/s41598-022-06774-8","volume":"12","author":"N Yasara","year":"2022","unstructured":"Yasara, N. et al. A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent beta-thalassaemia. Sci. Rep. 12, 2752. https:\/\/doi.org\/10.1038\/s41598-022-06774-8 (2022).","journal-title":"Sci. Rep."},{"key":"21010_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13023-021-01757-w","volume":"16","author":"N Yasara","year":"2021","unstructured":"Yasara, N., Premawardhena, A. & Mettananda, S. A comprehensive review of hydroxyurea for beta-haemoglobinopathies: The role revisited during COVID-19 pandemic. Orphanet J. Rare Dis. 16, 114. https:\/\/doi.org\/10.1186\/s13023-021-01757-w (2021).","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21010-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21010-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21010-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:53:41Z","timestamp":1761220421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21010-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21010"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21010-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval for the study was obtained from the Ethics Review Committee of the Sri Lanka College of Paediatricians (Reference number: SLCP\/ERC\/2024\/17). Informed consent was obtained from all study participants before recruitment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"37142"}}